-
Dixon Technolog.
13,300.00 10,613.00(%) -
Kerala Ayurveda
511.70 515.00(%) -
Ola Electric
43.20 45.06(%) -
Mazagon Dock
3,328.90 3,778.00(%) -
Bharat Electron
416.95 410.00(%) -
Waaree Energies
2,932.20 1,808.65(%) -
Garden Reach Sh.
3,386.70 3,528.00(%) -
Aeroflex
212.20 271.60(%) -
Suzlon Energy
62.10 46.00(%) -
Hind.Aeronautics
5,025.00 5,675.00(%) -
Paras Defence
1,710.00 1,943.60(%) -
Swiggy
378.00 297.00(%) -
Multi Comm. Exc.
8,154.65 8,108.35(%) -
Shilchar Tech.
5,435.00 6,125.00(%) -
Infosys
1,583.00 1,307.10(%) -
RattanIndia Pow.
13.54 8.44(%) -
Mishtann Foods
7.08 4.28(%) -
Bharat Dynamics
1,937.65 2,096.00(%) -
Trent
5,835.00 4,491.75(%) -
Indian Renewable
161.40 137.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Kwality Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 68403.0
- ISIN : INE552U01010
-
Today’s Low
1,010.10 -
Today’s High
1,059.00

-
Open
1,027.00 -
Perv Close
1,023.15 -
52W Low
481.00 -
52W High
1,140.00
Key Indicators
-
P/E(TTM)
26.85
-
Mar.Cap (₹Cr.)
1,070.88
-
Div & Yield %
0.00
-
Book Value(₹)
255.44
-
Debt-Equity Ratio
0.87
-
AGM Date
20-Jun-2025
-
EPS
38.44
-
P/E Ratio
26.85
Financials Ratios
-
Debt-Equity Ratio
0.45
-
Mar.Cap (₹Cr.)
1,070.88
-
RONW (%)
13.66
-
ROCE (%)
15.86
Score Board
-
Equity (₹ in Cr.)
10.38
-
BV (₹)
255.40
-
Sales( ₹ in Cr.)
370.20
-
NP (in Cr.)
39.89
-
NP Var(%)
36.0
-
Div%
0.0
-
CPS (₹)
56.00
-
EPS (₹)
38.40
-
Traded Value (₹ in Lakhs)
1,070.88
-
52 Week High
1,140.00
-
52 Week Low
481.00
-
Price BSE
1032.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
1,070.88
-
P/C Ratio
18.40
-
P/E Ratio
26.80
-
Price Vs.BV
38.40
-
20-May-2025( 04:17)
Hot Pursuit - Kwali... - <P> Sequentially, the company'...
-
20-May-2025( 07:45)
Results - Announcements - Kwali... - Net profit of Kwality Pharmace...
-
08-May-2025( 11:18)
Corporate News - Kwali... - Kwality Pharmaceuticals will...
-
07-May-2025( 11:33)
Corporate News - Kwali... - Kwality Pharmaceuticals will...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 307.17 | 250.99 | 456.13 | 261.50 | 138.68 | 165.15 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 307.17 | 250.99 | 456.13 | 261.50 | 138.68 | 165.15 |
Other Income | 1.83 | 2.94 | 3.51 | 1.59 | 3.92 | 0.93 |
Stock Adjustments | 1.48 | 3.20 | 2.51 | -0.09 | 5.52 | -5.15 |
Total Income | 310.48 | 257.13 | 462.15 | 263.00 | 148.12 | 160.93 |
EXPENDITURE : | ||||||
Raw Materials | 154.66 | 113.27 | 203.11 | 165.50 | 92.59 | 114.19 |
Power and Fuel Cost | 17.22 | 12.96 | 11.06 | 6.11 | 4.19 | 3.70 |
Employee Cost | 30.43 | 28.10 | 18.74 | 14.48 | 10.68 | 7.61 |
Other Manufacturing Expenses | 6.49 | 4.98 | 4.57 | 3.78 | 2.85 | 5.53 |
Selling and Administration Expenses | 30.74 | 32.57 | 48.71 | 41.12 | 19.43 | 13.50 |
Miscellaneous Expenses | 9.57 | 17.97 | 0.72 | 1.16 | 0.33 | 0.22 |
Employee Benefit Expenses | 30.43 | 28.10 | 18.74 | 14.48 | 10.68 | 7.61 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 249.12 | 209.85 | 286.91 | 232.14 | 130.06 | 144.75 |
Operating Profit | 61.37 | 47.29 | 175.24 | 30.86 | 18.05 | 16.17 |
Interest | 10.39 | 6.61 | 2.92 | 2.62 | 2.52 | 2.22 |
Gross Profit | 50.98 | 40.68 | 172.32 | 28.24 | 15.53 | 13.95 |
Depreciation | 19.51 | 14.92 | 10.64 | 6.44 | 4.39 | 3.06 |
Profit Before Tax | 31.47 | 25.76 | 161.68 | 21.80 | 11.14 | 10.89 |
Current Tax | 7.92 | 6.16 | 41.35 | 6.22 | 3.03 | 3.44 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -0.44 | 0.14 | 0.27 | 0.16 | -0.32 | -0.09 |
Reported Net Profit | 23.98 | 19.47 | 120.05 | 15.42 | 8.43 | 7.55 |
Extraordinary Items | -5.31 | -12.24 | 0.00 | -0.01 | 0.08 | 0.00 |
Adjusted Net Profit | 29.29 | 31.71 | 120.05 | 15.43 | 8.35 | 7.55 |
Adjustment below Net Profit | -0.06 | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 182.38 | 162.91 | 42.78 | 27.37 | 18.94 | 11.39 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | 206.30 | 182.38 | 162.91 | 42.78 | 27.37 | 18.94 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 23.11 | 18.76 | 115.69 | 14.86 | 8.13 | 7.27 |
Earnings Per Share(Adj)-Unit Curr | 23.11 | 18.76 | 115.69 | 14.86 | 8.13 | 7.27 |
Book Value | 216.98 | 193.93 | 175.17 | 59.47 | 44.62 | 36.49 |
Book Value(Adj)-Unit Curr | 216.98 | 193.93 | 175.17 | 59.47 | 44.62 | 36.49 |